Wednesday May 30 | AmericanBankingNews.com
Accuray Incorporated's "Neutral" Rating Reaffirmed at Zacks
's stock had its "neutral" rating restated by Zacks in a research report issued to clients and investors on Wednesday.
Full Breadth and Depth of Accuray's Advanced, Personalized Radiation...
SUNNYVALE, California, May 16, 2012 -- SUNNYVALE, California, May 16, 2012 /PRNewswire/ -- Conference Presentations Highlighted Benefits of the CyberKnife System's Motion Management and the TomoTherapy System's Daily Image-Guidance Accuray Incorporated , the premier radiation oncology company, announced today that for the first time in Europe, at ... (more)
Accuray Launches First Study to Compare CyberKnife? SBRT to Surgery...
Developments, news and strategies for drug development specific to phase I through Phase III global clinical trial management, execution, project management and outsourcing.